Skip to main content

Table 3 The proportion that each product contributes to the total number of products containing each potentially harmful excipient

From: Potentially harmful excipients in neonatal medications: a multicenter nationwide observational study in Japan

Excipients

Products name

N of prescription

(%)

N of neonates

(%)

Aspartame

Carbocystein dry syrup

6

(40.0%)

6

(40.0%)

Others

9

(60.0%)

9

(60.0%)

Ethanol

Soluble ferric pyrophosphate syrup

109

(56.5%)

109

(83.8%)

Alfacalcidol solution

66

(34.1%)

64

(49.2%)

Triclofos sodium oral syrup

14

(7.3%)

14

(10.8%)

Others

4

(2.1%)

4

(3.1%)

Benzalkonium chloride

Atropine ophthalmic solution

2

(33.3%)

2

(66.7%)

Others

4

(66.7%)

3

(100.0%)

Benzyl alcohol

Heparin sodium injections

126

(94.2%)

92

(91.1%)

Others

11

(5.8%)

10

(9.9%)

Parabens

Enema solution

49

(45.8%)

49

(52.7%)

Vitamin K2 oral syrup

28

(26.2%)

28

(30.1%)

Amicacin injections

10

(9.3%)

8

(8.6%)

Triclofos sodium oral syrup

14

(13.1%)

14

(15.1%)

Others

6

(5.6%)

6

(6.5%)

Polysorbate 80

Multivitamin injections

59

(51.3%)

57

(53.8%)

Erythropoietin injections

37

(32.2%)

35

(33.0%)

Others

19

(16.5%)

17

(16.0%)

Propylene glycol

Multivitamin injections

40

(56.3%)

38

(53.5%)

Vitamin K2 oral syrup

28

(39.4%)

28

(39.4%)

Others

3

(4.2%)

6

(8.5%)

Saccharin sodium

Multivitamin oral powders

66

(84.6%)

63

(95.5%)

Others

12

(15.4%)

9

(13.6%)

Sodium benzoate

Soluble ferric pyrophosphate syrup

109

(50.2%)

109

(71.2%)

Multivitamin oral powders

66

(30.4%)

63

(41.1%)

Vitamin K2 oral syrup

28

(12.9%)

28

(18.3%)

Others

14

(6.5%)

10

(6.5%)

Sorbitol

Soluble ferric pyrophosphate syrup

109

(64.1%)

109

(67.7%)

Vitamin K2 oral syrup

28

(16.5%)

28

(17.4%)

Vitamin K2 injection

26

(15.3%)

26

(16.1%)

Others

7

(4.1%)

7

(4.3%)